← Back to Search

Behavioural Intervention

Experimental Group for Autism Spectrum Disorder

Phase < 1
Recruiting
Led By Stacey Reynolds
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Study participants have to be 18+ years of age
Ability to communicate independently (verbally or via an alternative communication device) in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and after phase 1 (5 weeks) and 3 months post intervention
Awards & highlights

Study Summary

This trial is looking at how rideshare services could help autistic adults with transportation. Community mobility is important for living independently and being part of the community, especially for young adults. Some autistic adults struggle with

Who is the study for?
This trial is for early adult individuals with Autism Spectrum Disorder who may find it challenging to drive or use public transportation. It aims to help them live independently and engage in their community by teaching them how to effectively use rideshare services.Check my eligibility
What is being tested?
The study tests a training program designed to improve the ability of autistic adults to use rideshare apps for better community mobility. Participants will go through ride-along sessions, an intervention phase, and virtual training.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, participants might experience anxiety or stress related to new experiences during the training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can communicate in English on my own.
Select...
I have been diagnosed with ASD by a licensed doctor.
Select...
I can use a smartphone and get in and out of a car by myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and after phase 1 (5 weeks) and 3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and after phase 1 (5 weeks) and 3 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Autistic adults who have participated in the SRP program display greater independence in using Rideshare compared to autistic adults who did not participate in the SRP program (wait-list group)
Autistic adults who have participated in the SRP program display greater safety in using Rideshare compared to autistic adults who did not participate in the SRP program (wait-list group)?
Evaluate if the trainers conducting the SRP intervention find the intervention to be appropriate
+1 more
Secondary outcome measures
How do SRP participants use of Rideshare for community, social, and/or employment activities after the intervention
In the wait-list group, is there a change in community engagement, social participation, and employment from the waitlist phase (no intervention) to the 2-month follow-up period (after the intervention)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist GroupExperimental Treatment3 Interventions
The waitlist group receives no intervention (Phase 1) at first. After the 2-month intervention period, the waitlist group will receive the intervention, while the experimental group participates in a 2-month follow-up
Group II: Experimental GroupExperimental Treatment3 Interventions
The experimental group will receive the intervention first then a 2-month follow-up

Find a Location

Who is running the clinical trial?

Organization for Autism ResearchOTHER
6 Previous Clinical Trials
139 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
89 Patients Enrolled for Autism Spectrum Disorder
Virginia Commonwealth UniversityLead Sponsor
696 Previous Clinical Trials
22,885,082 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
349 Patients Enrolled for Autism Spectrum Disorder
Stacey ReynoldsPrincipal InvestigatorVirginia Commonwealth University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for eligible individuals to participate in this ongoing research study?

"The trial is actively enrolling participants as per clinicaltrials.gov. It was initially published on March 1, 2024, and last modified on March 14, 2024."

Answered by AI
~8 spots leftby Feb 2025